000 01356 a2200325 4500
005 20250515044246.0
264 0 _c20061129
008 200611s 0 0 eng d
022 _a1078-0432
024 7 _a10.1158/1078-0432.CCR-06-1211
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPowles, Trevor
245 0 0 _aOral bisphosphonates as adjuvant therapy for operable breast cancer.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cOct 2006
300 _a6301s-6304s p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdministration, Oral
650 0 4 _aBone Density Conservation Agents
_xadministration & dosage
650 0 4 _aBone Neoplasms
_xprevention & control
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aDiphosphonates
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aMcCroskey, Eugene
700 1 _aPaterson, Alexander
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 12
_gno. 20 Pt 2
_gp. 6301s-6304s
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-06-1211
_zAvailable from publisher's website
999 _c16637528
_d16637528